SCHEMBL7370638

SCHEMBL7370638

CCOC(=O)c1ccc(NC(=O)C(Cc2ccccc2)CP(=O)(O)OCC)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.57
SMN1; SMN2 Q16637 6/20 0.54
NPC1 O15118 3/20 0.54
GAA P10253 3/20 0.54
MAPT P10636 2/20 0.52
NAMPT P43490 1/20 0.52
THRB P10828 1/20 0.51
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
ALDH1A1 P00352 5/20 0.50
ALOX12 P18054 1/20 0.48
FPR2 P25090 1/20 0.48
KDM4E B2RXH2 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370619 0.91 RAB9A (0.58) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL7363583 0.90 RAB9A (0.60) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL7384102 0.80 MAPT (0.56) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL7384793 0.79 SMN1; SMN2 (0.54) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL7433755 0.79 RAB9A (0.59) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL28753025 0.78 MAPT (0.60) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL19805597 0.78 MAPT (0.60) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL28753021 0.77 RAB9A (0.57) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL28753023 0.77 RAB9A (0.57) RAB9ASMN1; SMN2NPC1GAAMAPT
SCHEMBL7382435 0.77 RAB9A (0.54) RAB9ASMN1; SMN2NPC1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0117429-B1 PHOSPHOROUS CONTAINING COMPOUNDS AS INHIBITORS OF ENKEPHALINASES SCHERING CORPORATION (US) 1987-09-02 EP disclosed
EP-0117429-A1 Phosphorous containing compounds as inhibitors of enkephalinases SCHERING CORPORATION (US) 1984-09-05 EP disclosed